These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20689075)

  • 1. Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization.
    Saif J; Schwarz TM; Chau DY; Henstock J; Sami P; Leicht SF; Hermann PC; Alcala S; Mulero F; Shakesheff KM; Heeschen C; Aicher A
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1897-904. PubMed ID: 20689075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
    Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb.
    Sun Q; Chen RR; Shen Y; Mooney DJ; Rajagopalan S; Grossman PM
    Pharm Res; 2005 Jul; 22(7):1110-6. PubMed ID: 16028011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.
    Nakagami H; Maeda K; Morishita R; Iguchi S; Nishikawa T; Takami Y; Kikuchi Y; Saito Y; Tamai K; Ogihara T; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2542-7. PubMed ID: 16224047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation.
    Marui A; Kanematsu A; Yamahara K; Doi K; Kushibiki T; Yamamoto M; Itoh H; Ikeda T; Tabata Y; Komeda M
    J Vasc Surg; 2005 Jan; 41(1):82-90. PubMed ID: 15696049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable multifunctional microgel encapsulating outgrowth endothelial cells and growth factors for enhanced neovascularization.
    Kim PH; Yim HG; Choi YJ; Kang BJ; Kim J; Kwon SM; Kim BS; Hwang NS; Cho JY
    J Control Release; 2014 Aug; 187():1-13. PubMed ID: 24852096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologically active microcarriers associated with thermosensitive hydrogel as a growth factor releasing biomimetic 3D scaffold for cardiac tissue-engineering.
    Karam JP; Muscari C; Sindji L; Bastiat G; Bonafè F; Venier-Julienne MC; Montero-Menei NC
    J Control Release; 2014 Oct; 192():82-94. PubMed ID: 24998940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powerful and controllable angiogenesis by using gene-modified cells expressing human hepatocyte growth factor and thymidine kinase.
    Hisaka Y; Ieda M; Nakamura T; Kosai K; Ogawa S; Fukuda K
    J Am Coll Cardiol; 2004 May; 43(10):1915-22. PubMed ID: 15145121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
    Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
    J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering.
    Liu Y; Teoh SH; Chong MS; Yeow CH; Kamm RD; Choolani M; Chan JK
    Tissue Eng Part A; 2013 Apr; 19(7-8):893-904. PubMed ID: 23102089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic mesenchymal stem cells have robust angiogenic properties and are effective in treating hindlimb ischaemia.
    Kim SW; Zhang HZ; Kim CE; An HS; Kim JM; Kim MH
    Cardiovasc Res; 2012 Mar; 93(3):525-34. PubMed ID: 22155484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
    Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
    J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors.
    Losi P; Briganti E; Magera A; Spiller D; Ristori C; Battolla B; Balderi M; Kull S; Balbarini A; Di Stefano R; Soldani G
    Biomaterials; 2010 Jul; 31(20):5336-44. PubMed ID: 20381861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host immune competence and local ischemia affects the functionality of engineered vasculature.
    Chen RR; Snow JK; Palmer JP; Lin AS; Duvall CL; Guldberg RE; Mooney DJ
    Microcirculation; 2007 Feb; 14(2):77-88. PubMed ID: 17365663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.
    Zhong Y; Zhang L; Ding AG; Shenderova A; Zhu G; Pei P; Chen RR; Mallery SR; Mooney DJ; Schwendeman SP
    J Control Release; 2007 Oct; 122(3):331-7. PubMed ID: 17706831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained improvement in perfusion and flow reserve after temporally separated delivery of vascular endothelial growth factor and angiopoietin-1 plasmid deoxyribonucleic acid.
    Smith AH; Kuliszewski MA; Liao C; Rudenko D; Stewart DJ; Leong-Poi H
    J Am Coll Cardiol; 2012 Apr; 59(14):1320-8. PubMed ID: 22464261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
    Shin SH; Lee J; Ahn DG; Lee KY
    Pharm Res; 2013 Aug; 30(8):2157-65. PubMed ID: 23686375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds.
    Kampmann A; Lindhorst D; Schumann P; Zimmerer R; Kokemüller H; Rücker M; Gellrich NC; Tavassol F
    Microvasc Res; 2013 Nov; 90():71-9. PubMed ID: 23899416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.